پارژیلین (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "پارژیلین" in Persian language version.

refsWebsite

Global rank Persian rank

2nih.gov

4^th place

5^th place

2doi.org

2^nd place

1jamanetwork.com

2,650^th place

2,401^st place

1bmj.com

1,226^th place

869^th place

1worldcat.org

5^th place

12^th place

1semanticscholar.org

11^th place

52^nd place

1fda.gov

447^th place

382^nd place

1books.google.com

3^rd place

6^th place

bmj.com (Global: 1,226^th place; Persian: 869^th place)

dtb.bmj.com

"Eutonyl and MAO inhibitors". Drug and Therapeutics Bulletin (به انگلیسی). 1 (15): 59–60. 15 November 1963. doi:10.1136/dtb.1.15.59. ISSN 1755-5248. S2CID 220162992. Pargyline is promoted only for the treatment of hypertension, and not for depression.

books.google.com (Global: 3^rd place; Persian: 6^th place)

Critical Reviews in Neurobiology. CRC Press. 1995. p. 43.

doi.org (Global: 2^nd place; Persian: 2^nd place)

Murphy DL, Karoum F, Pickar D, et al. (1998). "Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline)". J. Neural Transm. Suppl. Journal of Neural Transmission. Supplement. 52: 39–48. doi:10.1007/978-3-7091-6499-0_5. ISBN 978-3-211-83037-6. PMID 9564606.
"Eutonyl and MAO inhibitors". Drug and Therapeutics Bulletin (به انگلیسی). 1 (15): 59–60. 15 November 1963. doi:10.1136/dtb.1.15.59. ISSN 1755-5248. S2CID 220162992. Pargyline is promoted only for the treatment of hypertension, and not for depression.

fda.gov (Global: 447^th place; Persian: 382^nd place)

accessdata.fda.gov

FDA Eutonyl in the Drugs@FDA Database Accessed July 19, 2014

jamanetwork.com (Global: 2,650^th place; Persian: 2,401^st place)

jama.jamanetwork.com

Council on Drugs New Drugs and Developments in Therapeutics: Pargyline Hydrochloride (Eutonyl) JAMA. 1963;184(11):887. doi:10.1001/jama.1963.03700240079013.

nih.gov (Global: 4^th place; Persian: 5^th place)

pubmed.ncbi.nlm.nih.gov

Fisar Z, Hroudová J, Raboch J (2010). "Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers". Neuro Endocrinol Lett. 31 (5): 645–56. PMID 21200377.
Murphy DL, Karoum F, Pickar D, et al. (1998). "Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline)". J. Neural Transm. Suppl. Journal of Neural Transmission. Supplement. 52: 39–48. doi:10.1007/978-3-7091-6499-0_5. ISBN 978-3-211-83037-6. PMID 9564606.

semanticscholar.org (Global: 11^th place; Persian: 52^nd place)

api.semanticscholar.org

"Eutonyl and MAO inhibitors". Drug and Therapeutics Bulletin (به انگلیسی). 1 (15): 59–60. 15 November 1963. doi:10.1136/dtb.1.15.59. ISSN 1755-5248. S2CID 220162992. Pargyline is promoted only for the treatment of hypertension, and not for depression.

worldcat.org (Global: 5^th place; Persian: 12^th place)

"Eutonyl and MAO inhibitors". Drug and Therapeutics Bulletin (به انگلیسی). 1 (15): 59–60. 15 November 1963. doi:10.1136/dtb.1.15.59. ISSN 1755-5248. S2CID 220162992. Pargyline is promoted only for the treatment of hypertension, and not for depression.

پارژیلین (Persian Wikipedia)

bmj.com (Global: 1,226th place; Persian: 869th place)

dtb.bmj.com

books.google.com (Global: 3rd place; Persian: 6th place)

doi.org (Global: 2nd place; Persian: 2nd place)

fda.gov (Global: 447th place; Persian: 382nd place)